Life Science Big News Roundup: RISE Announces Hemp-based CBD Products for Sports Recovery and PMS; Kalytera Reports Data for First Cohort in Phase 2 Clinical Study
In case you missed it, here is this week’s life science big news roundup.
bluebird bio Opens State-of-the-Art Gene and Cell Therapy Manufacturing Facility
bluebird bio (NASDAQ:BLUE) has announced the opening of its first wholly owned manufacturing facility in Durham, North Carolina, which will...
Immutep Announces United States Patent Grant for Eftilagimod Alpha in Cancer
Immutep (ASX:IMM,NASDAQ:IMMP) has announced it has received the grant of a new patent called “Use of Recombinant LAG-3 on the...
Sorrento Therapeutics Announces Merger of Scilex and Semnur
Sorrento Therapeutics (NASDAQ:SRNE) has announced its majority-owned subsidiary Scilex Pharmaceuticals will merge with Semnur Pharmaceuticals to form a new company,...
resTORbio Announces Closing Public Offering of Common Stock
resTORbio (NASDAQ:TORC) has announced the closing of a previously announced underwritten public offering of 7.2 million shares of its common...
Kalytera Reports Data for First Cohort in Phase 2 Clinical Study Evaluating CBD in Prevention of Acute GVHD
Kalytera Therapeutics, Inc. (TSXV:KALY, OTC:KALTF) (the "Company" or "Kalytera") today announced positive data from its ongoing Phase 2 clinical study evaluating...
Cardiol Therapeutics Releases Video on Pharmaceutical CBD Market
Cardiol Therapeutics Inc. (TSX:CRDL) (OTC:CRTPF) has released a video regarding the progress it has made in development of its pharmaceutical-grade CBD...